CS202069B2 - Method of preparing 2-/4-substituted piperazine-1-yl/-4-amino-6,7-dimethoxyquinazolines - Google Patents

Method of preparing 2-/4-substituted piperazine-1-yl/-4-amino-6,7-dimethoxyquinazolines Download PDF

Info

Publication number
CS202069B2
CS202069B2 CS773960A CS396077A CS202069B2 CS 202069 B2 CS202069 B2 CS 202069B2 CS 773960 A CS773960 A CS 773960A CS 396077 A CS396077 A CS 396077A CS 202069 B2 CS202069 B2 CS 202069B2
Authority
CS
Czechoslovakia
Prior art keywords
formula
hydrogen
iii
defined above
process according
Prior art date
Application number
CS773960A
Other languages
Czech (cs)
English (en)
Inventor
Philip D Hammen
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to CS793864A priority Critical patent/CS202071B2/cs
Priority to CS793863A priority patent/CS202070B2/cs
Publication of CS202069B2 publication Critical patent/CS202069B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CS773960A 1976-06-15 1977-06-15 Method of preparing 2-/4-substituted piperazine-1-yl/-4-amino-6,7-dimethoxyquinazolines CS202069B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CS793864A CS202071B2 (cs) 1976-06-15 1979-06-05 Způsob přípravy 2-(4-substituovaných piperazin-1-yl)-4-amino-6,7- -dimethoxychinazolinů
CS793863A CS202070B2 (cs) 1976-06-15 1979-06-05 Způsob přípravy 2-(4-substituovaných piperazin-1-yl)-4-amino-6,7- -dimethoxychinazolinů

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69620176A 1976-06-15 1976-06-15

Publications (1)

Publication Number Publication Date
CS202069B2 true CS202069B2 (en) 1980-12-31

Family

ID=24796111

Family Applications (1)

Application Number Title Priority Date Filing Date
CS773960A CS202069B2 (en) 1976-06-15 1977-06-15 Method of preparing 2-/4-substituted piperazine-1-yl/-4-amino-6,7-dimethoxyquinazolines

Country Status (34)

Country Link
JP (1) JPS52153985A (sv)
AR (1) AR218251A1 (sv)
AT (1) AT356115B (sv)
BE (1) BE855656A (sv)
BG (3) BG35747A3 (sv)
CA (1) CA1068698A (sv)
CH (3) CH638203A5 (sv)
CS (1) CS202069B2 (sv)
DD (1) DD131021A5 (sv)
DE (1) DE2725019A1 (sv)
DK (1) DK146625C (sv)
EG (1) EG12922A (sv)
ES (1) ES459364A1 (sv)
FI (1) FI66853C (sv)
FR (1) FR2355015A1 (sv)
GB (1) GB1548856A (sv)
GR (1) GR72288B (sv)
HK (1) HK31481A (sv)
HU (1) HU177883B (sv)
IE (1) IE45423B1 (sv)
IL (1) IL52167A (sv)
LU (1) LU77530A1 (sv)
MY (1) MY8100270A (sv)
NL (1) NL172543C (sv)
NO (1) NO147838C (sv)
NZ (1) NZ184168A (sv)
PH (1) PH22196A (sv)
PL (3) PL113012B1 (sv)
PT (1) PT66617B (sv)
RO (3) RO73050A (sv)
SE (2) SE435380B (sv)
SU (2) SU1033002A3 (sv)
YU (1) YU40164B (sv)
ZA (1) ZA773014B (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346675A1 (de) * 1983-12-23 1985-07-04 Beiersdorf Ag, 2000 Hamburg Substituierte 1-(4-amino-6,7-dialkoxy-chinazolinyl)-4- cyclohexenyl-derivate des piperazins und homopiperazins, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen und zwischenprodukte
AT384218B (de) * 1985-12-04 1987-10-12 Gerot Pharmazeutika Verfahren zur herstellung von neuen chinazolin-derivaten
CA2077252C (en) * 1992-08-31 2001-04-10 Khashayar Karimian Methods of making ureas and guanidines, and intermediates therefor
IL112249A (en) 1994-01-25 2001-11-25 Warner Lambert Co Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
US5654307A (en) * 1994-01-25 1997-08-05 Warner-Lambert Company Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
IL112248A0 (en) 1994-01-25 1995-03-30 Warner Lambert Co Tricyclic heteroaromatic compounds and pharmaceutical compositions containing them
US5932538A (en) * 1996-02-02 1999-08-03 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3511836A (en) 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
US3669968A (en) 1970-05-21 1972-06-13 Pfizer Trialkoxy quinazolines
JPS536156B2 (sv) * 1972-10-30 1978-03-04
US3935213A (en) 1973-12-05 1976-01-27 Pfizer Inc. Process for hypotensive 4-amino-2-(piperazin-1-yl) quinazoline derivatives
JPS50126682A (sv) * 1974-03-25 1975-10-04

Also Published As

Publication number Publication date
PL111221B1 (en) 1980-08-30
JPS52153985A (en) 1977-12-21
FR2355015B1 (sv) 1981-07-24
BG35748A3 (en) 1984-06-15
SE450120B (sv) 1987-06-09
NZ184168A (en) 1979-08-31
CH638517A5 (en) 1983-09-30
IL52167A0 (en) 1977-07-31
DK146625B (da) 1983-11-21
PH22196A (en) 1988-06-28
NO771919L (no) 1977-12-16
DK240877A (da) 1977-12-16
AR218251A1 (es) 1980-05-30
GR72288B (sv) 1983-10-17
CH638203A5 (en) 1983-09-15
NO147838C (no) 1983-06-22
BG35747A3 (en) 1984-06-15
PL198874A1 (pl) 1978-04-10
NL172543C (nl) 1983-09-16
SU946402A3 (ru) 1982-07-23
RO77330A (ro) 1981-06-22
ZA773014B (en) 1978-04-26
BG35594A3 (en) 1984-05-15
AU2558377A (en) 1978-09-07
DD131021A5 (de) 1978-05-24
SE435380B (sv) 1984-09-24
IE45423B1 (en) 1982-08-25
CH638516A5 (en) 1983-09-30
FR2355015A1 (fr) 1978-01-13
IL52167A (en) 1981-01-30
CA1068698A (en) 1979-12-25
IE45423L (en) 1977-12-15
NO147838B (no) 1983-03-14
HU177883B (en) 1982-01-28
YU40164B (en) 1985-08-31
RO77308A (ro) 1981-08-17
JPS5543465B2 (sv) 1980-11-06
NL172543B (nl) 1983-04-18
GB1548856A (en) 1979-07-18
EG12922A (en) 1980-03-31
PT66617B (en) 1978-10-27
AT356115B (de) 1980-04-10
PL105558B1 (pl) 1979-10-31
PL113012B1 (en) 1980-11-29
BE855656A (fr) 1977-12-14
YU132677A (en) 1982-08-31
SE7705745L (sv) 1977-12-16
PT66617A (en) 1977-06-01
FI66853B (fi) 1984-08-31
ATA386977A (de) 1979-09-15
FI771741A (sv) 1977-12-16
RO73050A (ro) 1981-08-30
LU77530A1 (fr) 1979-03-26
DE2725019A1 (de) 1977-12-22
SU1033002A3 (ru) 1983-07-30
MY8100270A (en) 1981-12-31
SE8107554L (sv) 1981-12-16
ES459364A1 (es) 1978-03-16
HK31481A (en) 1981-07-10
DK146625C (da) 1984-06-04
FI66853C (fi) 1984-12-10
NL7705939A (nl) 1977-12-19

Similar Documents

Publication Publication Date Title
RU2096411C1 (ru) Производные бензимидазолона, смеси их изомеров или их кислотно-аддитивные соли в качестве антагониста рецептора 5-ht*00i*00a и 5-нт*002
US6566372B1 (en) Bicyclic androgen and progesterone receptor modulator compounds and methods
JP5285652B2 (ja) モルホリン誘導体の化学合成
JPH07215972A (ja) 5−ht1a−拮抗活性を有する2,3−ジヒドロ−1,4−ベンゾジオキシン−5−イル−ピペラジン誘導体
JPH07188207A (ja) 1−[2h−1−ベンゾピラン−2−オン−8−イル]−ピペラジン誘導体
CS202069B2 (en) Method of preparing 2-/4-substituted piperazine-1-yl/-4-amino-6,7-dimethoxyquinazolines
EP1075473B1 (en) Process for making 1,3-disubstituted-4-oxocyclic ureas
RU1838309C (ru) Способ получени производных хиназолина или их формацевтически приемлемых кислотно-аддитивных солей
CZ294957B6 (cs) Způsob přípravy substituované imidazopyridinové sloučeniny
RU2295521C2 (ru) Фотохромные оксазиновые соединения и способы их производства
SU999967A3 (ru) Способ получени 6-N-замещенных 6-амино-3-пиридазинилгидразинов или их солей
CS202070B2 (cs) Způsob přípravy 2-(4-substituovaných piperazin-1-yl)-4-amino-6,7- -dimethoxychinazolinů
JPS6410514B2 (sv)
US4282358A (en) Process for the production of substituted N-methylbenzoxazines
KR810000293B1 (ko) 치환아미노 퀴나졸린 유도체의 제조방법
DK146510B (da) 2-(4-(2-furoyl)piperazin-1-yl)-4-phthalimido-6,7-dimethoxyquinazolin til anvendelse som mellemprodukt ved fremstilling af 2-(4-(2-furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazolin
DD297971A5 (de) Verfahren zur herstellung von chinazolinderivaten
JPS60233074A (ja) イミダゾ〔1,2−a〕ピリジン誘導体
JPH1112254A (ja) 3−(3−ピリジルメチルアミノ)−3,4−ジヒドロ−2(1h)−キナゾリノン誘導体及びその中間体の製造方法
JPS63112580A (ja) テトラヒドロピリド〔2,3−d〕ピリミジン誘導体
GB2039885A (en) N-phenyl-N'-acyl-S- alkylisothiocarbamides
JPH0625161B2 (ja) 2−アニリノ−1,6−ジヒドロ−6−オキソ−5−ピリミジンカルボン酸誘導体の製造法
MXPA00012725A (en) Chemical synthesis of morpholine derivatives
JPH0413356B2 (sv)
JPH0332552B2 (sv)